SEC 13F Intelligence

Birchview Capital, LP / PRTA

Birchview Capital, LP’s Prothena Corp PLC Position

Does Birchview Capital, LP own Prothena Corp PLC (PRTA)? Yes449.0K shares worth $4M (+2.48% of its 13F portfolio) as of Q1 2026, up from 441.0K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
449.0K
% of Portfolio
+2.48%
Quarters Held
20
currently held

Position History PRTA

Reported value by quarter
Q2 ’21: $2MQ2 ’21Q3 ’21: $3MQ4 ’21: $2MQ1 ’22: $2MQ1 ’22Q2 ’22: $3MQ3 ’22: $7MQ4 ’22: $8MQ4 ’22Q1 ’23: $6MQ2 ’23: $11MQ3 ’23: $8MQ3 ’23Q4 ’23: $6MQ1 ’24: $4MQ2 ’24: $4MQ2 ’24Q3 ’24: $4MQ4 ’24: $4MQ1 ’25: $4MQ1 ’25Q2 ’25: $3MQ3 ’25: $5MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026449.0K$4M+2.48%
Q4 2025441.0K$4M+2.47%
Q3 2025549.0K$5M+4.05%
Q2 2025451.0K$3M+2.72%
Q1 2025333.0K$4M+3.58%
Q4 2024304.6K$4M+3.44%
Q3 2024209.6K$4M+3.04%
Q2 2024203.6K$4M+3.89%
Q1 2024169.6K$4M+3.43%
Q4 2023169.6K$6M+4.83%
Q3 2023169.6K$8M+6.96%
Q2 2023156.1K$11M+7.99%
Q1 2023128.4K$6M+4.87%
Q4 2022127.2K$8M+5.41%
Q3 2022118.9K$7M+5.08%
Q2 2022102.5K$3M+2.03%
Q1 202242.0K$2M+1.11%
Q4 202140.2K$2M+1.28%
Q3 202140.2K$3M+1.95%
Q2 202130.2K$2M+0.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of PRTA.